Table 2.

 Changes in HLE gene expression by ephrin-Al-Fc stimulation

Gene category	Gene name	Cy5/Cy3 ratio
Cell cycle	H sapiens RBQ-1	3.12
	RB107 retinoblastoma-like 1 (p107)	2.38
	RB130 retinoblastoma-like 2	2.13
	Cyclin D2	0.46
	p21	0.40
Angiogenesis	Endothelin 2	2.30
	Endothelin 3	2.22
	Laminin, α4	2.22
	Bone morphogenetic protein 4 (BMP4)	2.16
	Angiopoietin 1 (Ang1)	2.12
	Inhibin, βA (activin A, activin AB alpha polypeptide)	2.07
	Fibroblast growth factor receptor 3	1.85
	Laminin, γ1 (formerly LAMB2)	0.68
	Bone morphogenetic protein 1 (BMP1)	0.68
	Thrombospondin 1 (TSP-1)	0.47
Cell-cell interaction	CD22 antigen	2.41
	Rho6 protein	1.95
	CD36 antigen (collagen type I receptor, thrombospondin receptor)	1.94
	Matrix metalloproteinase 12 (MMP-12)	1.89
	Ras homologue gene family, member H	1.88
	Manic fringe (Drosophila) homologue	1.88
	Integrin, α2 (CD49B, alpha 2 subunit of VLA-2 receptor)	1.83
	Integrin, αM	1.81
	Matrix metalloproteinase 2 (MMP-2)	1.56
	CD44 antigen (homing function and Indian blood group system)	0.68
Oncogene	Alpha-fetoprotein (AFP)	1.91
	Met proto-oncogene (hepatocyte growth factor receptor)	0.52
	Vav 2 oncogene	0.59
Growth factors and cytokines	Tachykinin 2	2.31
	Interleukin 5	0.59
	Fibroblast growth factor 7 (keratinocyte growth factor)	0.50
Cell receptor	Interleukin 5 receptor, α	3.12
	Erythropoietin receptor	2.12
	Glutamate receptor, ionotropic, kainate 1	1.90
	EphA1 receptor	1.82
Signal transduction	Human 76 kDa tyrosine phosphoprotein SLP-76 extracellular signal regulated kinase 2 (ERK2)
		0.53
Stress and toxicology response	Cytochrome P450, subfamily IIC	1.95
Transcription factors	Hepatic leukaemia factor	2.30
	Nuclear factor I/X (CCAAT binding transcription factor)	2.11
	Human Ikaros/LyF-1 homologue (hIk-1)	2.04
Tumour suppressors	BRCA1 associated RING domain 1	1.95
Cytoskelton	Keratin, type II cytoskeletal 6D	0.42